Mayo Clinic announced the launch of Precure, LLC, with founding partner Thermo Fisher Scientific, to help transform how the life sciences community understands the biological changes that occur as people move from health toward disease.

Precure, LLC will create one of the world's leading biomedical datasets through one of the largest human multi-omics data generation efforts, integrating proteomic, genomic and longitudinal clinical data to help researchers identify early biological signals of disease and provide a foundation for new discoveries in disease biology, diagnostics and therapeutics.

Precure, LLC will bring together molecular data generated from one million biospecimens, linked with longitudinal clinical information collected over several years, integrating genomic and proteomic information with Mayo Clinic's clinical data and expertise in a highly standardized setting. Advanced AI and large-scale data analytics will be integral to identifying patterns within these complex datasets and translating them into actionable insights. Mayo Clinic will serve as the majority owner of Precure, LLC. Thermo Fisher joins the partnership as a minority owner.

WilmerHale advised Thermo Fisher in the partnership.

The WilmerHale team was led by Jekkie Kim and Judith Hasko, and included Tom Ward, Andrew Langworthy, Rob Finkel, Hal Leibowitz, Mizuna Sekine, Frank Wang, Kyle Kessler, Mat Trachok, Cassie Shapiro on corporate, licensing, and commercial transactions matters, Meghan Walsh on tax matters, and Ariella Feingold on employment matters.